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Background: Change in serotonin transporter (SERT) function has been implicated in 
autism. SERT function is influenced by the number of transporter molecules present at 
the cell surface, which is regulated by various cellular mechanisms including 
interactions with other proteins. Thus, we searched for novel SERT-binding proteins 
and investigated. As we presented at the IMFAR 2014, N-ethylmaleimide-sensitive 
factor (NSF) was identified as a novel SERT-binding protein. NSF co-localized with 
SERT at the plasma membrane, and NSF knockdown resulted in decreased SERT 
expression at the cell membranes and its uptake function in HEK293-hSERT cells. In 
addition, NSF endogenously co-localized with SERT and interacted with SERT in 
mouse brain. 
Objectives: The objectives of this study were to address whether expressions of SERT 
and NSF were changed in autism and whether these expression correlate with clinical 
variables and symptom profiles. 
Methods: We examined the mRNA expression of SERT (SLC6A4) and NSF in the 
post-mortem brains from 7 subjects with autism and 11 healthy age- and sex-matched 
control subjects, and in the lymphocytes from 30 male subjects with autism and 30 male 
healthy age-matched control subjects by quantitative real-time PCR. Additionally, we 
evaluated the relationships between these expression levels and clinical variables and 
symptom profiles. 
Results: While SLC6A4 expression was not significantly changed, NSF expression 
tended to be reduced in post-mortem brains, however this potential trend is not 
statistically significant, and was significantly reduced and correlated with the severity of 
the clinical symptom in lymphocytes of subjects with autism. 
 
